BeiGene Management
Management criteria checks 2/4
BeiGene's CEO is John Oyler, appointed in Jan 2010, has a tenure of 14.83 years. total yearly compensation is CN¥134.33M, comprised of 4.6% salary and 95.4% bonuses, including company stock and options. directly owns 3.52% of the company’s shares, worth HK$5.54B. The average tenure of the management team and the board of directors is 3.2 years and 4.3 years respectively.
Key information
John Oyler
Chief executive officer
CN¥134.3m
Total compensation
| CEO salary percentage | 4.6% |
| CEO tenure | 14.8yrs |
| CEO ownership | 3.5% |
| Management average tenure | 3.2yrs |
| Board average tenure | 4.3yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -CN¥6b |
| Jun 30 2024 | n/a | n/a | -CN¥4b |
| Mar 31 2024 | n/a | n/a | -CN¥6b |
| Dec 31 2023 | CN¥134m | CN¥6m | -CN¥6b |
| Sep 30 2023 | n/a | n/a | -CN¥7b |
| Jun 30 2023 | n/a | n/a | -CN¥13b |
| Mar 31 2023 | n/a | n/a | -CN¥13b |
| Dec 31 2022 | CN¥124m | CN¥6m | -CN¥14b |
| Sep 30 2022 | n/a | n/a | -CN¥15b |
| Jun 30 2022 | n/a | n/a | -CN¥14b |
| Mar 31 2022 | n/a | n/a | -CN¥12b |
| Dec 31 2021 | CN¥106m | CN¥5m | -CN¥9b |
| Sep 30 2021 | n/a | n/a | -CN¥9b |
| Jun 30 2021 | n/a | n/a | -CN¥9b |
| Mar 31 2021 | n/a | n/a | -CN¥8b |
| Dec 31 2020 | CN¥94m | CN¥5m | -CN¥11b |
| Sep 30 2020 | n/a | n/a | -CN¥10b |
| Jun 30 2020 | n/a | n/a | -CN¥10b |
| Mar 31 2020 | n/a | n/a | -CN¥8b |
| Dec 31 2019 | CN¥88m | CN¥5m | -CN¥7b |
| Sep 30 2019 | n/a | n/a | -CN¥6b |
| Jun 30 2019 | n/a | n/a | -CN¥5b |
| Mar 31 2019 | n/a | n/a | -CN¥5b |
| Dec 31 2018 | CN¥192m | CN¥4m | -CN¥5b |
| Sep 30 2018 | n/a | n/a | -CN¥3b |
| Jun 30 2018 | n/a | n/a | -CN¥2b |
| Mar 31 2018 | n/a | n/a | -CN¥923m |
| Dec 31 2017 | CN¥67m | CN¥3m | -CN¥606m |
Compensation vs Market: John's total compensation ($USD18.54M) is above average for companies of similar size in the Hong Kong market ($USD906.43K).
Compensation vs Earnings: John's compensation has increased whilst the company is unprofitable.
CEO
John Oyler (56 yo)
14.8yrs
Tenure
CN¥134,331,046
Compensation
Mr. John V. Oyler Co-Founded BeiGene, Ltd. and has been its Chief Executive Officer since 2010. Mr. Oyler Co-founded BioDuro, LLC and served as its Chief Executive Officer and President from 2005 to 2009....
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.8yrs | CN¥134.33m | 3.52% HK$ 5.5b | |
| President & COO | 6.5yrs | CN¥78.08m | 0.056% HK$ 87.4m | |
| Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder | 14.8yrs | CN¥31.35m | 0.83% HK$ 1.3b | |
| General Counsel & Senior VP | 2.3yrs | CN¥28.74m | 0.017% HK$ 27.0m | |
| Global Head of R&D | no data | CN¥51.93m | 0.13% HK$ 203.2m | |
| CFO & Principal Financial Officer | less than a year | no data | no data | |
| VP & Chief Accounting Officer | less than a year | no data | 0.0033% HK$ 5.3m | |
| Head of Investor Relations | no data | no data | no data | |
| Chief Compliance Officer | 1.1yrs | no data | no data | |
| Senior VP & Head of Public Affairs - Greater China | 3.8yrs | no data | no data | |
| Senior VP & Chief Medical Officer for Solid Tumors | 2.8yrs | no data | no data | |
| Global Head of Human Resources | 3.7yrs | no data | no data |
3.2yrs
Average Tenure
56yo
Average Age
Experienced Management: 6160's management team is considered experienced (3.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder | 14.1yrs | CN¥134.33m | 3.52% HK$ 5.5b | |
| Co-Chairman of Scientific Advisory Board & Non-Executive Director and Co-Founder | 8.8yrs | CN¥31.35m | 0.83% HK$ 1.3b | |
| Acting Head of Medicinal Chemistry & Member of Scientific Advisory Board | 3.6yrs | no data | no data | |
| Independent Non-Executive Director & Member of the Scientific Advisory Committee | 9.6yrs | CN¥3.42m | 0.0034% HK$ 5.3m | |
| Independent Non-Executive Director & Member of Scientific Advisory Committee | 4.3yrs | CN¥3.56m | 0.0022% HK$ 3.4m | |
| Independent Non-Executive Director | 4.8yrs | CN¥3.64m | 0.0027% HK$ 4.3m | |
| Director | less than a year | no data | no data | |
| Co-Chairman of Scientific Advisory Committee & Independent Non-Executive Director | 2.8yrs | CN¥3.49m | 0.0021% HK$ 3.4m | |
| Independent Non-Executive Director | less than a year | no data | 0% HK$ 0 | |
| Independent Lead Director | 10.1yrs | CN¥3.46m | 0.0034% HK$ 5.3m | |
| Member of Scientific Advisory Board & Independent Non-Executive Director | 2.8yrs | CN¥3.62m | 0.0021% HK$ 3.4m |
4.3yrs
Average Tenure
62yo
Average Age
Experienced Board: 6160's board of directors are considered experienced (4.3 years average tenure).